ArticleTranslational cancer research2025

Targeting the METTL3/PCNA axis with STM2457 overcomes cisplatin resistance in osteosarcoma.

Hua Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.